Autoantibody profile in African-American patients with lupus nephritis

Abstract

Lupus nephritis (LN) is one of the major risk factors for morbidity and overall mortality in systemic lupus erythematosus (SLE). Its pathogenesis is multifactorial, and a number of risk factors, including serological markers, have been identified in recent years, correlating with clinical course and disease severity. Furthermore, a distinctive autoantibody profile has recently been reported in African- American SLE women with LN. The aim of this study was to characterize the autoantibody profile in 222 African-American SLE patients, 94 with LN and 128 without. Only anti-dsDNA achieved statistical significance between the two groups (P < 0.05). Fourteen (14.9%) patients with LN and 15 (11.7%) without it exhibited positive anti-Ro/SS-A, anti-Sm, and anti-nRNP, but without anti-La/SS B (P > 0.6). We conclude that African-American SLE patients with LN do not exhibit a specific or distinctive autoantibody profile. However, our data confirm the value of anti-dsDNA in SLE patients with LN.

Keywords

African-American autoantibody profile ethnicity lupus nephritis systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Ballou SP , Khan MA , Kushner I. Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum 1982 ; 25: 55-60.

Ward MM , Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Inter Med 1991; 91: 343-353.

Citera G. , Wilson WA Ethnic and geographical perspectives in SLE. Lupus 1993; 2: 351-353.

Walker WG , Solez K. Renal involvement in disorders of connective tissues. In: Earley LE , Gottschalk CW (eds). Diseases of Kidneys, vol. 2. Little, Brown: Boston 1979; 1259-1288.

Ginzler EM et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.. Arthritis Rheum 1982; 25: 601-611.

Hill SS Systemic lupus erythematosus and mixed connective tissue disease. In: Heptinstall RH (ed). Pathology of the Kidney, vol. 2, Little, Brown: Boston, 1992;, 871-950.

Bakir AA , Levy PS , Dunea G. The prognosis of lupus nephritis in African-Americans: A retrospective analysis . Am J Kidney Dis 1994; 24: 159-171.

Arnett FC et al. Increased frequencies of Sm and nRNP autoantibodies in American black compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773-1776.

Molina JF et al. Ethnic differences in the clinical expression of systemic lupus erythematosus. (submitted for publication)

10.

Tan EM , Schur PH , Carr RI , Kunkel HG Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 1966; 45: 1732-1740.

11.

Woods VL Pathogenesis of systemic lupus erythematosus. In: Kelley WN , Harris ED , Ruddy S , Sledge CB (eds). Textbook of Rheumatology. W. B. Saunders Co.: Philadelphia, 1993, 999-1016.

12.

Mannik M. Immune complexes. In: Lahita RD (ed). Systemic Lupus Erythematosus. Churchill Livingstone : New York, 1992, 327-341.

13.

Stetler DA , Cavallo T. Anti-RNA polymerase I antibodies: potential role in the induction and progression of murine lupus nephritis. J Immunol 1987; 138: 2119-2123.

14.

Termaat RM et al. Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes. Lab Invest 1993; 68: 164-173.

15.

Bernestein KA , Kahl LE , Balow JE , Lefkowith JB Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity . Clin Exp Immunol 1994; 98: 60-65.

16.

Mosca M. et al. Lupus nephritis: Can the serological profile predict the outcome ?. Lupus 1995; 4: 143 (abstract).

17.

Houssiau FA et al. Lupus nephritis: The significance of serological tests at the time of biopsy. Clin Exp Rheumatol 1991; 9: 345-349.

18.

McCarty GA , Harley JB , Reichlin M. A distinctive autoantibody profile in black female patients with lupus nephritis . Arthritis Rheum 1993; 36: 1560-1565.

19.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982; 25: 1271-1277.

20.

Gharavi AE, Harris En, Asherson RA, Hughes GRV Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.

21.

Garcia CO et al. Intravenous cyclophosphamide (IVCY) therapy for severe lupus nephritis. Arthritis Rheum 1995; 38 (suppl): S347.

22.

Howard TW et al. Rheumatoid factor, cryoglobulinemia, anti-DNA, and renal disease in patients with systemic lupus erythematosus. J Rheumatol 1991; 18: 826-830.

23.

Cochrane CG , Koffer D. Immune complex disease in experimental animals and man. Adv Immunol 1973; 16: 185-264.

24.

Koffer D. , Schur PH , Kunkel HG Immunological studies concerning the nephritis of systemic lupus erythematosus . J Exp Med 1967; 126: 607-623.

25.

Lloyd W. , Schur PH Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus. Medicine (Baltimore ) 1981; 60: 208-217.

26.

Miniter MF , Stollar BD , Agnello V Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 959-968.

27.

Weisbart RH et al. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus . J Immunol 1990; 144: 2653-2658.

28.

Wasicek CA , Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La . J Clin Invest 1982; 69: 835-843.

29.

Hamilton RG et al. Two Ro (SS-A) antibody responses in systemic lupus erythematosus: Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31: 496-505.

30.

Harley JB et al. A model of disease heterogeneity of systemic lupus erythematosus. Relationship between histocompatibility antigens, autoantibodies, and lymphopenia to renal disease. Arthritis Rheum 1989; 32: 826-836.

31.

Reichlin M. , Mattioli M. Correlation of a precipitin reaction to an RNA protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus . N Eng J Med 1972; 86: 908-911.

32.

Joseph J. et al. Absence of a distinctive autoantibody profile in black women with lupus nephritis. Arhritis Rheum 1994; 37: 1261-1262 (letter).

33.

Scopelitis E. , Biundo JJ , Alspaugh A. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum 1980; 25: 287-293.

34.

Wilson WA , Scopelitis E. , Michalski JP Association of HLA-DR7 with both antibody to SS-A (Ro) and disease susceptibility in blacks with systemic lupus erythematosus. J Rheumatol 1984; 11: 653-657.

35.

Von Mhlem CA , Tan EM Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-358.

36.

Harley JB Autoantibodies are central to the diagnosis and clinical manifestations of lupus. J Rheumatol 1994; 21: 1183-1185.